Boston University School of Medicine

Supplemental training

Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists


CME information


  Create an account or log in to participate in this activity

Pharmacists Special Instructions

To receive credit for this module, you must complete a post-test and evaluation at the University of Rhode Island College of Pharmacy website. After watching the video, follow these instructions!

Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists is an online educational program for prescribers, pharmacists, and other healthcare providers that will help you prevent overdoses among your patients and their social networks. Through the program you will see videos of patient-pharmacist-prescriber encounters that model how to provide a patient overdose education and a naloxone rescue kit.

The program also includes very brief instructional videos for the available naloxone rescue kit formulations designed for you to use with your patients.

By participating in this program, you will learn learn how to:

  1. Explain the epidemiology of overdose
  2. Explain the rational for and scope of overdose prevention education and naloxone rescue kit distribution;
  3. Incorporate overdose prevention education and naloxone rescue kits into medical and pharmacy practice by
    1. Educating patients about overdose risk reduction and
    2. Furnishing naloxone rescue kits
  4. Explain the legal and policy environment regarding furnishing naloxone rescue kits

This program is provided by Boston University School of Medicine and is supported by the Substance Abuse and Mental Health Services Administration of the US Department of Health and Human Services. It offers continuing education for physicians, pharmacists, nurse practitioners, physician assistants, and nurses.

The online program is a companion to the website www.prescribetoprevent.org, which includes resources to help health care providers educate their patients to reduce overdose risk and provide naloxone rescue kits to patients and their social networks.

In addition to all the individuals whose work made this program possible, we would like to particularly thank the University of Rhode Island for the use of the School of Pharmacy Building and CVS/Caremark for access to film in the Model Pharmacy. In addition, we would like to thank the following individuals for their invaluable assistance during the video shoot:

Accreditation

Physicians

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Boston University School of Medicine designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This program meets the criteria of the Massachusetts Board of Registration in Medicine for 1.25 hours of risk management study.

This program meets the criteris of the Massachusetts Board of Registration in Medicine for 1.25 hours of opioid prescribing education.

Nurses

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Contact Hours: 1.25, all of which is pharmacology credit-worthy.

Continuing Pharmacy Education Information acpeThe University of Rhode Island, College of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Completion of the entire online program and completion of online evaluations and self-assessment tools at the conclusion of the program are required for reporting continuing education credit to the National Association of Boards of Pharmacy via the CPE Monitor. This is a knowledge based learning activity.

Universal activity number: UAN 0060-9999-14-062-H01-P
Contact hours: 1.25 Contact Hours (0.125 CEUs)
Initial Activity Release Date: 10/15/14
Activity Update: 09/09/16
Date of Most Recent Review: 9/30/18
Activity Expiration Date: 09/30/19

In order to receive credit, participants must view the content of the program and complete the post-test and evaluation. Participants who receive a grade of 70% or greater on the post-test will receive credit.

Support

This program is provided by Boston University School of Medicine and is supported by the Substance Abuse and Mental Health Services Administration of the US Department of Health and Human Services.

Target Audience

Physicians, pharmacists, nurse practitioners, physician assistants, and nurses.

Educational Objectives

At the conclusion of this activity, participants will be able to:

For questions about CME, please contact cme@bu.edu or www.bu.edu/cme.

To view Boston University’s Privacy Policy, please see http://www.bumc.bu.edu/cme/policies/.

Disclosure Policy

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

Faculty

Daniel P. Alford, MD, MPH, FACP (Course Director)
Professor of Medicine
Boston University School of Medicine
Boston Medical Center
Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that he does not plan to discuss unlabeled/investigational uses of a commercial product.
dan.alford@bmc.org

Alexander Y. Walley, MD, MSc (Course Co-Director)
Assistant Professor of Medicine
Co-Program Director, Addiction Medicine Fellowship Program Program
Director, Fellow Immersion Training Program
Boston University School of Medicine and Boston Medical Center
Faculty member is a consultant for Social Sciences Innovation Research, Inc. Faculty member indicates that he does plan to discuss unlabeled/investigational uses of a commercial product. The intra-nasal delivery of naloxone is not approved by the FDA.

Donna Beers BSN, RN-BC, CARN
Nurse Manager
TOPCARE Project
Boston Medical Center
Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that he does not plan to discuss unlabeled/investigational uses of a commercial product.

Jeffrey Bratberg, PharmD, BCPS
Clinical Professor of Pharmacy
University of Rhode Island College of Pharmacy
Infectious Disease Specialist
Roger Williams Medical Center, Providence, RI
Faculty member is a consultant for and on the speakers bureau for Merck, and on the speakers bureau for Sanofi Pasteur. Faculty member indicates that he does plan to discuss unlabeled/ investigational uses of a commercial product. The intra-nasal delivery of naloxone is not approved by the FDA.

Corey Davis, JD, MSPH
Deputy Director
The Network for Public Health Law
Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that he does plan to discuss unlabeled/investigational uses of a commercial product. The intra-nasal delivery of naloxone is not approved by the FDA.

Traci Green, PhD, MSc, Video Actor; and Nkiruka Emeagwali, MD, Video Actor, have nothing to disclose with regards to commercial support. They do discuss unlabeled/investigational uses of a commercial product. The intra-nasal delivery of naloxone is not approved by the FDA.

Ilana Hardesty, Program Operations Manager, Boston University School of Medicine CME Office, has nothing to disclose with regards to commercial support.

Disclaimer

THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.

Boston University Council of Medical Specialty Societies Federation of State Medican Boards